Mutational profile of previously treated chronic lymphocytic leukemia patients progressing on acalabrutinib or ibrutinib.
Woyach JA, Jones D, Jurczak W, Robak T Prof, Illes A, Kater AP, Ghia P, Byrd JC, Seymour JF, Long S, Mohamed N, Benrashid S, Lai TH, De Jesus G, Lai R, de Bruin G, Rule S, Munugalavadla V.
Woyach JA, et al. Among authors: long s.
Blood. 2024 May 16:blood.2023023659. doi: 10.1182/blood.2023023659. Online ahead of print.
Blood. 2024.
PMID: 38754046